Company / Assets per Share
Intellia Therapeutics, Inc. Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$8.25
FY2025
5-year range
$8.25 / $20.41
FY2021-FY2025
Trend
-35.6%
vs FY2024
Sector context
#141 of 163
Health Care
What the data says
Intellia Therapeutics, Inc.'s assets per share of $8.25 is lower than 87% of companies in the Health Care sector (FY2025). Assets per Share has declined for 3 consecutive years, from $20.41 in FY2022 to $8.25 in FY2025.
Based on SEC 10-K filings.
8.25 in FY2025 with a 5-year CAGR of -9.3%.
Declined from $14.94 to $8.25 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -26.0%
- 5-Year CAGR
- -9.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 163This company $8.25 Sector average $114.70
▼
-92.8% below sector average
Key checks
Key Insights
- Intellia Therapeutics, Inc.'s assets per share has declined for 3 consecutive years.
- In FY2025, assets per share decreased 35.6% year-over-year.
- Ranks #141 out of 163 companies in the Health Care sector.
- Peak assets per share was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.14 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.25 | -35.6% |
| FY2024 | $12.81 | -14.3% |
| FY2023 | $14.94 | -26.8% |
| FY2022 | $20.41 | +4.4% |
| FY2021 | $19.54 | +45.1% |
| FY2020 | $13.47 | +82.3% |
| FY2019 | $7.39 | -9.8% |
| FY2018 | $8.19 | -21.6% |
| FY2017 | $10.45 | -22.3% |
| FY2016 | $13.45 | -96.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026